Name: Enlisting Liquid Biopsies in the Fight Against Chronic Diseases by The Bioverge Podcast
Duration: 57 min 14 s
Description: Nathan Hunkapiller, Chief Scientific Officer and Co-Founder of Curve Biosciences, sits down with Neil to discuss liquid biopsies, the company’s efforts to expand the use of these blood-based tests to improve the treatment of chronic diseases, and how it is enabling earlier intervention.

Anthony DePasqua, CEO of EnClear Therapies, sits down with Neil to discuss the company’s technology in development to remove toxic proteins from cerebrospinal spinal fluid to treat patients with ALS and other neurodegenerative conditions.

Removing Toxins from Cerebrospinal Fluid to Treat Neurodegenerative Diseases

Nathan Hunkapiller, Chief Scientific Officer and Co-Founder of Curve Biosciences, sits down with Neil to discuss liquid biopsies, the company’s efforts to expand the use of these blood-based tests to improve the treatment of chronic diseases, and how it is enabling earlier intervention.

Enlisting Liquid Biopsies in the Fight Against Chronic Diseases

Join Neil Littman on The Bioverge Podcast as he explores the intersection of bio x tech and features the entrepreneurs, investors, and industry leaders who are revolutionizing healthcare and bringing science fiction to life.

Enlisting Liquid Biopsies in the Fight Against Chronic Diseases

The Bioverge Podcast

Related tracks